Search The Source

N.M. Stat. Ann. § 26-1-2 – New Mexico

Status: Enacted

Amends the New Mexico Drug, Device and Cosmetic Act to allow pharmacists to substitute biosimilar and interchangeable biosimilar biologic products for another biologic product that has been prescribed by a physician.

Associated Litigation:

No items found

Leave A Comment